Latest Shareholder Value News

Askari Metals has completed its acquisition of the Nejo Gold and Copper Project in Ethiopia, gaining a strategic foothold in a prolific gold-copper belt. With active exploration underway and strong financial backing, the company is poised to accelerate resource development.

Alicanto Minerals has appointed seasoned resources executive Jeffrey Sansom as CEO, signaling a strategic push to advance its Falun Copper-Gold Project and pursue new acquisitions. The leadership change aligns with the company’s ambitions to enhance shareholder value through disciplined growth.

New Frontier Minerals advances its Harts Range heavy rare earths project with imminent drilling and secures a strategic alliance to develop its NWQ copper assets, positioning itself strongly in critical minerals supply.

Aura Energy’s 2025 AGM highlights strong uranium market fundamentals and strategic progress on its Tiris Project, despite some engineering delays. The company also strengthens its board and deepens ties in Mauritania as it prepares for production.

West African Resources is advancing negotiations with the Burkina Faso Government over equity interests in its Kiaka gold project, proposing alternatives to direct government ownership to boost national benefits without diluting shareholder value.

Perseus Mining has extended its on-market share buy-back program by another year, signaling cautious capital management amid uncertain market conditions. The company has yet to acquire shares under the program but remains poised to act depending on evolving factors.

Vault Minerals has settled all its gold forward sales contracts for the second half of FY26 six months early, boosting its exposure to rising gold prices and reinforcing its shareholder value strategy.

MPR Australia Limited has completed the sale of its core renewable energy business for $19 million and is now exploring options including returning capital to shareholders or acquiring a new business via backdoor listing.

Microequities Asset Management Group Limited has announced an on-market buy-back of up to 13.27 million shares, representing roughly 10% of its issued capital, signaling a strategic capital management move.

Jameson Resources Limited has updated its Employee Share Option Plan, approved at the 2025 AGM, aiming to better incentivize and retain key personnel while aligning employee interests with shareholders.

Mesoblast has achieved a landmark FDA approval for RYONCIL, the first allogeneic mesenchymal stromal cell therapy, driving strong commercial momentum and advancing a robust pipeline targeting inflammatory diseases.

Tartana Minerals has secured a $1.275 million placement priced at a 17% premium, including significant director participation pending shareholder approval. The capital raise aims to strengthen working capital and retire convertible notes, supporting advancement of its Chillagoe assets.